Institute of Translational Pharmacology (IFT), National Research Council (CNR), via Fosso del Cavaliere 100, 00133, Rome, Italy.
Complex Structure of Geriatrics, Department of Medical Sciences, IRCCS Casa Sollievo della Sofferenza, Viale Cappuccini 1, 71013, San Giovanni Rotondo, Foggia, Italy.
Mol Neurobiol. 2017 Dec;54(10):8386-8403. doi: 10.1007/s12035-016-0304-6. Epub 2016 Dec 8.
Serotonin (5-HT) is a neurotransmitter that regulates fundamental aspects of brain development, physiology and behaviour. The serotonin transporter (5-HTT) is deputized to the reuptake of 5-HT from the intersynaptic space in the presynaptic neurons. 5-HTT governs duration and magnitude of 5-HT biological actions, acting as a master regulator of the fine-tuning of 5-HT signalling. Genetic variation at SLC6A4 gene locus, encoding 5-HTT, contributes to alteration in 5-HT reuptake. The 5-HTTLPR/rs25531/rs25532 polymorphisms located in the promoter region of SLC6A4 gene have been associated with stress-related psychopathology and functional brain phenotypes. Besides, further DNA variations in functional regulative elements located at 5' and 3' termini of the SLC6A4 gene influence transcriptional and post-transcriptional steps. Recently, epigenetic processes including SLC6A4 promoter methylation and transcript silencing by microRNA were shown to be involved in the aetiology of affective disorders. Furthermore, gene-environment interactions such as early life stress often encompass epigenetic changes, which can stably mark the genome in response to environmental stimuli potentially altering gene expression across lifespan. Therefore, it seems well established that functional variations in the SLC6A4 gene expression can no longer be ascribed to the modulating 5-HTTLPR promoter polymorphism but need to be integrated with the contribution arising from other interactive elements and epigenetic mechanisms. In this review, we discuss genetic and epigenetic layers of regulation affecting SLC6A4 gene expression. An overview of human and cellular studies investigating the impact of these regulatory processes on SLC6A4 gene expression is provided.
血清素(5-HT)是一种神经递质,调节大脑发育、生理和行为的基本方面。血清素转运体(5-HTT)负责将 5-HT 从突触前神经元的突触间隙中重新摄取。5-HTT 控制 5-HT 生物学作用的持续时间和幅度,作为 5-HT 信号精细调节的主要调节剂。SLC6A4 基因座编码 5-HTT 的基因变异导致 5-HT 再摄取的改变。位于 SLC6A4 基因启动子区域的 5-HTTLPR/rs25531/rs25532 多态性与应激相关的精神病理学和功能性大脑表型有关。此外,位于 SLC6A4 基因 5'和 3'末端的功能调节元件中的进一步 DNA 变异影响转录和转录后步骤。最近,包括 SLC6A4 启动子甲基化和 miRNA 转录沉默在内的表观遗传过程被证明与情感障碍的发病机制有关。此外,基因-环境相互作用,如早期生活压力,通常包含表观遗传变化,这些变化可以稳定地标记基因组,以响应环境刺激,可能会改变整个生命周期的基因表达。因此,似乎可以肯定的是,SLC6A4 基因表达的功能变异不能再归因于调节 5-HTTLPR 启动子多态性,而是需要与其他相互作用元素和表观遗传机制的贡献相结合。在这篇综述中,我们讨论了影响 SLC6A4 基因表达的遗传和表观遗传调控层。提供了人类和细胞研究的概述,这些研究调查了这些调节过程对 SLC6A4 基因表达的影响。